The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
α 2 -Adrenergic Mechanisms in Prefrontal Cortex Associated with Cognitive Decline in Aged Nonhuman Primates
Abstract
This study provides evidence that the α 2 -adrenergic receptor agonist clonidine ameliorates the cognitive deficits exhibited by aged nonhuman primates through drug actions at α 2 receptors. Furthermore, pharmacological profiles in animals with lesions restricted to the dorsolateral prefrontal cortex indicate that this area may be the site of action for some of clonidine's beneficial effects. These results demonstrate that α-adrenergic systems contribute to cognitive function and suggest a new strategy for treating memory disorders in aged humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although previous research focused on presynaptic receptor actions, research has established that the beneficial effects of α2-agonists arise from stimulation of postsynaptic α2A-receptors in the PFC (Arnsten and Goldman-Rakic, 1985; Cai et al., 1993).”
From Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders (2011) · cites this paper as Arnsten and Goldman-Rakic, 1985
In the citing paper
“Thus, either depletion of noradrenaline52 or blockade of α2A-receptors in the PFC53 impairs working memory, whereas stimulation of postsynaptic α2A-receptors in the PFC improves working memory performance52,56–58.”
From Stress signalling pathways that impair prefrontal cortex structure and function (2009) · cites this paper as [52]
In the citing paper
“As shown in FIG. 2, the levels of noradrenaline that are released during alert, non-stressed waking optimize working memory by engaging α2A-receptors52,53, whereas the high levels of noradrenaline that are released during stress impair PFC function by stimulating lower-affinity α1-receptors54 and β1-receptors55.”
From Stress signalling pathways that impair prefrontal cortex structure and function (2009) · cites this paper as [52]
In the citing paper
“Either depletion of NE (35) or blockade of α2A receptors in PFC (36) impairs working memory performance in monkeys, suggesting that endogenous NE plays a large role in strengthening working memory performance.”
From Catecholamine Influences on Dorsolateral Prefrontal Cortical Networks (2011) · cites this paper as [35]
In the citing paper
“Conversely, stimulation of postsynaptic α2A receptors in dorsolateral PFC, e.g., with guanfacine infusions directly into this region, improves working memory performance (35,41–43).”
From Catecholamine Influences on Dorsolateral Prefrontal Cortical Networks (2011) · cites this paper as [35]
In the citing paper
“Data from studies of monkey dorsolateral PFC demonstrate an inverted-U dose-response: moderate levels of NE released during alert, nonstressed waking improve working memory performance by engaging postsynaptic, α2A receptors (35,36), whereas high levels of NE released during stress impair PFC function via stimulation of lower affinity α1 (37) and β1 receptors (38).”
From Catecholamine Influences on Dorsolateral Prefrontal Cortical Networks (2011) · cites this paper as [35]
In the citing paper
“In contrast, guanfacine mimics the enhancing effects of norepinephrine at postsynaptic α2A-receptors in the PFC, strengthening network connectivity.”
From Catecholamine Influences on Dorsolateral Prefrontal Cortical Networks (2011) · cites this paper as [35]
In the citing paper
“The beneficial effects of α2-AR agonists for higher cognitive function were first discovered in aged monkeys (Arnsten et al., 1988, Arnsten and Goldman-Rakic, 1985)”
From Guanfacine’s mechanism of action in treating prefrontal cortical disorders: Successful translation across species (2020) · cites this paper as Arnsten and Goldman-Rakic, 1985
In the citing paper
“early research determined that the beneficial effects of α2-AR agonists on cognition arose from postsynaptic receptor actions in the PFC (Arnsten and Goldman-Rakic, 1985, Cai et al., 1993), with a pharmacological profile consistent with the α2A-AR subtype (Arnsten et al., 1988, Arnsten and Leslie, 1991), a finding later confirmed in genetically altered mice (Franowicz et al., 2002).”
From Guanfacine’s mechanism of action in treating prefrontal cortical disorders: Successful translation across species (2020) · cites this paper as Arnsten and Goldman-Rakic, 1985
In the citing paper
“Early studies discovered that α2-AR agonists markedly improved working memory performance in young monkeys with experimental catecholamine depletion in the dlPFC, with effects consistent with actions at post-synaptic receptors in the dlPFC (Arnsten & Goldman-Rakic, 1985).”
From Guanfacine’s mechanism of action in treating prefrontal cortical disorders: Successful translation across species (2020) · cites this paper as Arnsten & Goldman-Rakic, 1985
Citations
Cites
The cholinergic hypothesis of geriatric memory dysfunction
Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S. (1982) · Science · doi:10.1126/science.7046051 · Cited by 5,545
Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain
Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Squire, L. R. (1984) · Springer eBooks · doi:10.1007/978-3-642-70094-1_32 · Cited by 2,130
Cognitive Deficit Caused by Regional Depletion of Dopamine in Prefrontal Cortex of Rhesus Monkey
Brozoski, T. J., Brown, R. M., Rosvold, H. E., & Goldman, P. S. (1979) · Science · doi:10.1126/science.112679 · Cited by 1,500
Self-citationAsher, R. (1961) · The Lancet · doi:10.1016/s0140-6736(61)91217-x · Cited by 1,293
Localization of function within the dorsolateral prefrontal cortex of the rhesus monkey
Goldman, P. S., & Rosvold, H. E. (1970) · Experimental Neurology · doi:10.1016/0014-4886(70)90222-0 · Cited by 580
Assessment in Geriatric Psychopharmacology
Hynie, S. (1986) · Neuropharmacology · doi:10.1016/0028-3908(86)90122-x · Cited by 498
Cell loss in the locus coeruleus in senile dementia of Alzheimer type
Tomlinson, B. E., Irving, D., & Blessed, G. (1981) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(81)90031-9 · Cited by 453
Changes in the Brain Catecholamines in Patients with Dementia of Alzheimer Type
Adolfsson, R., Gottfries, C. G., Roos, B. E., & Winblad, B. G. (1979) · The British Journal of Psychiatry · doi:10.1192/bjp.135.3.216 · Cited by 449
Flagged first, then by citations
Research works printed but not linked: 8
- Bartus, R. T., Aging 10: 85 (1979).
- FORNO, L.S., LOCUS CAERULEUS IN ALZHEIMERS-DISEASE, JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 37: 614 (1978).
- LOCKHART, M.P., SOCIETY FOR NEUROSCIENCE. ABSTRACTS 10: 995 (1984).
- SLADEK, J.R., AGING 17: 13 (1981).
- WALKER, B, SOCIETY FOR NEUROSCIENCE. ABSTRACTS 10: 64 (1984).
- Wang C. H. Journal of Neuroscience in press.
- WINBLAND, B, AGING 19: 26 (1982).
- Zornetzer, S. F., Neuropsychology of Memory: 588 (1984).
Cited by
Sorted by citations
Items 201–300 of 548
Festa, E. K., Ott, B. R., & Heindel, W. C. (2004) · Neuropsychology · doi:10.1037/0894-4105.18.2.258 · Cited by 67
Role of Norepinephrine in the Pathophysiology of Neuropsychiatric Disorders
Ressler, K. J., & Nemeroff, C. B. (2001) · CNS Spectrums · doi:10.1017/s1092852900001358 · Cited by 65
The effects of 5-HT3 receptor antagonists on cognitive performance in aged monkeys
Arnsten, A. F. T., Lin, C. H., van Dyck, C. H., & Stanhope, K. J. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(96)00162-5 · Cited by 67
Self-citationScopolamine Reduces Frontal Cortex Perfusion
Honer, W. G., Prohovnik, I., Smith, G. S., & Lucas, L. (1988) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1988.110 · Cited by 66
Clonidine enhances delayed matching-to-sample performance by young and aged monkeys
Jackson, W. J., & Buccafusco, J. J. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90400-v · Cited by 66
Vos, H. D., Convents, A., Keyser, J. D., Backer, J. D., Megen, I. J. B. V., Ebinger, G., & Vauquelin, G. (1991) · Brain Research · doi:10.1016/0006-8993(91)91675-q · Cited by 64
Ji, X.-H., Ji, J.-Z., Zhang, H., & Li, B.-M. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301603 · Cited by 61
Convents, A., Convents, D., Backer, J. D., Keyser, J. D., & Vauquelin, G. (1989) · Biochemical Pharmacology · doi:10.1016/0006-2952(89)90385-7 · Cited by 62
Pharmacological models of ADHD
Kostrzewa, R. M., Kostrzewa, R. A., Kostrzewa, R. A., Nowak, P. G., & Brus, R. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-007-0826-1 · Cited by 61
Azami, N., Piri, M., Oryan, S., Jahanshahi, M., Babapour, V., & Zarrindast, M. (2010) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2010.01.003 · Cited by 61
Ross, J. A., Gliebus, G. P., & Bockstaele, E. J. V. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.08.004 · Cited by 63
Carlson, S., Tanila, H., Pia Rämä, A., Mecke, E., & Pertovaara, A. (1992) · Behavioral and Neural Biology · doi:10.1016/0163-1047(92)90327-z · Cited by 61
Yang, L., Cao, Q., Shuai, L., Li, H., Chan, R. C. K., & Wang, Y. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001490 · Cited by 63
Franowicz, J. S. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00060-3 · Cited by 62
Synaptic input to cochlear nucleus dendrites that receive medial olivocochlear synapses
Benson, T. E., Berglund, A. M., & Brown, M. C. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19960129)365:1 · Cited by 62
Neurochemical and Behavioral Sequelae of Exposure to Dioxins and PCBs
Seegal, R. F., & Schantz, S. L. (1994) · Springer eBooks · doi:10.1007/978-1-4899-1462-0_13 · Cited by 60
Mohs, R. C., Shiovitz, T. M., Tariot, P. N., Porsteinsson, A. P., Baker, K. D., & Feldman, P. D. (2009) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181aad585 · Cited by 59
Adrenergic and serotonergic receptors in aged monkey neocortex
Bigham, M. H., & Lidow, M. S. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)80012-g · Cited by 59
Hao, S., Avraham, Y., Bonne, O. B., & Berry, E. M. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00448-2 · Cited by 59
CLONIDINE: UNDERSTANDING ITS DISPOSITION, SITES AND MECHANISM OF ACTION
Jarrott, B., Conway, E. L., Maccarrone, C., & Lewis, S. J. (1987) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1987.tb00999.x · Cited by 59
Boellner, S. W., Pennick, M., Fiske, K. S., Lyne, A., & Shojaei, A. (2007) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.9.1253 · Cited by 60
Halperin, J. M., Newcorn, J. H., Koda, V. H., Pick, L. H., McKay, K. E., & Knott, P. J. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199712000-00017 · Cited by 57
Kalaria, R. N., & Andorn, A. C. (1991) · Neurobiology of Aging · doi:10.1016/0197-4580(91)90051-k · Cited by 57
The Korsakoff syndrome: a neurochemical perspective
McEntee, W. J., & Mair, R. G. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90146-2 · Cited by 57
Arnsten, A. F. T., Joyce, M. K. P., & Roberts, A. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.105000 · Cited by 64
Self-citationPharmacological and therapeutic directions in ADHD: Specificity in the PFC
Lévy, F. (2008) · Behavioral and Brain Functions · doi:10.1186/1744-9081-4-12 · Cited by 58
Barnett, J. H., Xu, K., Heron, J., Goldman, D. A., & Jones, P. B. (2010) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31150 · Cited by 58
Age-related prefrontal alterations during auditory memory
Chao, L. L., & Knight, R. T. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(96)00161-3 · Cited by 54
Sawaguchi, T. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.80.4.2200 · Cited by 55
Neuropharmacologic and Behavioral Actions of Clonidine: Interactions With Central Neurotransmitters
Buccafusco, J. J. (1992) · International review of neurobiology · doi:10.1016/s0074-7742(08)60691-1 · Cited by 55
Alpha-2 Adrenergic Receptors and Attention-Deficit/Hyperactivity Disorder
Bidwell, L. C., Dew, R. E., & Kollins, S. H. (2010) · Current Psychiatry Reports · doi:10.1007/s11920-010-0136-4 · Cited by 55
Alpha2C-adrenoceptor overexpression disrupts execution of spatial and non-spatial search patterns
Björklund, M., Sirviö, J., Sallinen, J., Scheinin, M., Kobilka, B. K., & Riekkinen, P. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00306-6 · Cited by 54
Kobori, N., Hu, B., & Dash, P. K. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2010.10.048 · Cited by 53
Pharmacological evidence for the implication of noradrenaline in effort
Borderies, N., Mattioni, J., Bornert, P., Gilardeau, S., & Bouret, S. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000793 · Cited by 49
Tanila, H., Mustonen, K., Sallinen, J., Scheinin, M., & Riekkinen, P. J. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00464.x · Cited by 53
Noradrenaline in the aging brain: Promoting cognitive reserve or accelerating Alzheimer's disease?
Mather, M. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.05.013 · Cited by 57
Björklund, M., Sirviö, J., Puoliväli, J. T., Sallinen, J., Jäkälä, P., Scheinin, M., Kobilka, B. K., & Riekkinen, P. J. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.3.569 · Cited by 52
Karkanias, G. B., Li, C.-S., & Etgen, A. M. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00359-x · Cited by 51
α2-Adrenoceptors and I2 sites in the mammalian central nervous system
French, N. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)02005-5 · Cited by 51
Collier, T. J., Greene, J. G., Felten, D. L., Felten, S. Y., & Steece‐Collier, K. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00042-3 · Cited by 50
PET imaging of neocortical monoaminergic terminals in Parkinson's disease
Marie, R., Barré, L., Rioux, P. P., Allain, P., Lechevalier, B., & Baron, J. (1995) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02252963 · Cited by 53
Aston‐Jones, G., Gonzalez, M., & Doran, S. M. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544156.007 · Cited by 51
The locus coeruleus and regulation of behavioral flexibility and attention: clinical implications
Aston‐Jones, G., Iba, M., Clayton, E. C., Rajkowski, J., & Cohen, J. D. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544156.008 · Cited by 49
Overexpression of Alpha2C-adrenoceptors impairs water maze navigation
Björklund, M., Sirviö, J., Riekkinen, M., Sallinen, J., Scheinin, M., & Riekkinen, P. J. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00428-5 · Cited by 49
Grasby, P. M., Friston, K. J., Bench, C. J., Frith, C., Paulesu, E., Cowen, P. J., Liddle, P. F., Frackowiak, R. S. J., & Dolan, R. J. (1992) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1992.tb00145.x · Cited by 48
Alpha-2 agonist-induced memory impairment is mediated by the alpha-2A-adrenoceptor subtype
Galeotti, N., Bartolini, A., & Ghelardini, C. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.12.016 · Cited by 54
The effects of aging on the frequency of nerve fibers in rhesus monkey striate cortex
Nielsen, K. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00169-x · Cited by 51
Raskind, M. A., Peskind, E. R., Veith, R. C., Beard, J. C., Gumbrecht, G., & Halter, J. B. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-2-438 · Cited by 48
Effects of α-2A adrenergic receptor agonist on time and risk preference in primates
Kim, S., Bobeica, I., Gamo, N. J., Arnsten, A. F. T., & Lee, D. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2520-0 · Cited by 47
Self-citationMair, R. D., Zhang, Y., Bailey, K. R., Toupin, M. M., & Mair, R. D. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2263-x · Cited by 45
Transgenic models of α2-adrenergic receptor subtype function
Hein, L. (2008) · Springer eBooks · doi:10.1007/bfb0117493 · Cited by 47
Mediation of separation distress byα2-adrenergic mechanisms in a non-human primate
Harris, J. C., & Newman, J. D. (1987) · Brain Research · doi:10.1016/0006-8993(87)90337-4 · Cited by 46
Clonidine Treatment of Alzheimer's Disease
Mohr, E., Schlegel, J. R., Fabbrini, G., Williams, J. A., Mouradian, M. M., Mann, U. M., Claus, J. J., Fedio, P., & Chase, T. N. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520400030015 · Cited by 45
Neurobiological Models of Aging in the Dog and Other Vertebrate Species
Head, E., Milgram, N. W., & Cotman, C. W. (2001) · Elsevier eBooks · doi:10.1016/b978-012351830-9/50032-9 · Cited by 45
Behavioral Models of Aging in Nonhuman Primates
Dean, R. L., & Bartus, R. T. (1988) · Springer eBooks · doi:10.1007/978-1-4613-0933-8_8 · Cited by 45
Scullion, G. A., Kendall, D. A., Marsden, C. A., Sunter, D., & Pardon, M. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.09.002 · Cited by 44
Neurotransmitters in neocortex of aged rhesus monkeys
Beal, M. F., Walker, L. C., Storey, E., Segar, L., Price, D. L., & Cork, L. C. (1991) · Neurobiology of Aging · doi:10.1016/0197-4580(91)90065-r · Cited by 44
Brailowsky, S., Silva‐Barrat, C., Ménini, C., RICHE, D., & Naquet, R. (1989) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(89)90176-4 · Cited by 43
Geffen, G. M., Wright, M. J., Green, H. J., Gillespie, N. A., Smyth, D. C., Evans, D. M., & Geffen, L. B. (1997) · Journal of Cognitive Neuroscience · doi:10.1162/jocn.1997.9.6.743 · Cited by 43
Catecholamine mechanisms in age-related cognitive decline
Arnsten, A. F. T. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90054-f · Cited by 44
Self-citationα2-Adrenoceptors are targets for antipsychotic drugs
Brosda, J., Jantschak, F., & Pertz, H. H. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3459-8 · Cited by 45
D’Andrea, I., Fardella, V., Fardella, S., Pallante, F., Ghigo, A., Iacobucci, R., Maffei, A., Hirsch, E., Lembo, G., & Carnevale, D. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404697 · Cited by 42
Dierolf, A. M., Schoofs, D., Hessas, E.-M., Falkenstein, M., Otto, T., Paul, M., Boris Suchan, A., & Wolf, O. T. (2018) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2018.08.020 · Cited by 51
Effects of music and white noise on working memory performance in monkeys
Carlson, S., Pia Rämä, A., Artchakov, D., & Linnankoski, I. (1997) · Neuroreport · doi:10.1097/00001756-199709080-00010 · Cited by 43
Cerebral Glucose Metabolism and Memory in Aged Rhesus Macaques
Eberling, J. L., Roberts, J., Rapp, P. R., Tuszynski, M. H., & Jagust, W. J. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00040-7 · Cited by 43
NE/DA interactions in prefrontal cortex and their possible roles as neuromodulators in schizophrenia
Tassin, J. (1992) · Springer eBooks · doi:10.1007/978-3-7091-9211-5_7 · Cited by 42
Moffoot, A. P. R., O’Carroll, R. E., Murray, C. L., Dougall, N. J., Ebmeier, K. P., & Goodwin, G. M. (1994) · Psychological Medicine · doi:10.1017/s0033291700026829 · Cited by 43
Epidural Clonidine or Bupivacaine as the Sole Analgesic Agent during and after Abdominal Surgery
Kock, M. D., Gautier, P. E., Pavlopoulou, A., Jonniaux, M., & Lavand'homme, P. M. (1999) · Anesthesiology · doi:10.1097/00000542-199905000-00020 · Cited by 42
Dopamine and memory function in Parkinson's disease
Mohr, E., Fabbrini, G., Williams, J. A., Schlegel, J. R., Cox, C., Fedio, P., & Chase, T. N. (1989) · Movement Disorders · doi:10.1002/mds.870040202 · Cited by 42
Cognitive changes during normal aging in monkeys assessed with an automated test apparatus
Voytko, M. L. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90055-g · Cited by 42
Metrifonate effects on acetylcholine and biogenic amines in rat cortex
Mori, F., Cuadra, G. R., & Giacobini, E. (1995) · Neurochemical Research · doi:10.1007/bf00995563 · Cited by 42
Bartus, R. T., & Dean, R. L. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1365-7 · Cited by 40
Prevention approaches in a preclinical canine model of Alzheimer’s disease: benefits and challenges
Davis, P. R., & Head, E. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00047 · Cited by 43
Kelly, S. C., McKay, E. C., Beck, J. S., Collier, T. J., Dorrance, A. M., & Counts, S. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190090 · Cited by 44
Idazoxan potentiates rather than antagonizes some of the cognitive effects of clonidine
Middleton, H. C., Sharma, A., Agouzoul, D., Sahakian, B. J., & Robbins, T. W. (1999) · Psychopharmacology · doi:10.1007/s002130051074 · Cited by 41
Age-related reduction in responses of rat hippocampal neurons to locally applied monoamines
Bickford, P. C., Miller, J. A., Freedman, R., & Rose, G. (1988) · Neurobiology of Aging · doi:10.1016/s0197-4580(88)80047-2 · Cited by 41
Meana, J. J., Barturen, F., Garro, M. A., García‐Sevilla, J. A., Fontán, A., & Zarranz, J. J. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10067.x · Cited by 43
Haroutunian, V. H., Santucci, A. C., & Davis, K. L. (1990) · Progress in brain research · doi:10.1016/s0079-6123(08)60917-6 · Cited by 41
Trovero, F., Blanc, G., Hervé, D., Vezina, P., Glowinski, J., & Tassin, J. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90121-h · Cited by 40
Potential Noradrenergic Targets for Cognitive Enhancement in Schizophrenia
Friedman, J. I., Stewart, D. G., & Gorman, J. M. (2004) · CNS Spectrums · doi:10.1017/s1092852900009330 · Cited by 39
Effect of sex and age on brain monoamines and spatial learning in rats
Tanila, H., Taira, T., Piepponen, P. T., & Honkanen, A. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90056-6 · Cited by 41
Monoaminergic Innervation of Cingulate Cortex
Crino, P. B., Morrison, J. H., & Hof, P. R. (1993) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4899-6704-6_10 · Cited by 39
Bickford, P. C. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)80313-2 · Cited by 39
Camacho, F., Smith, C. P., Vargas, H. M., & Winslow, J. T. (1996) · Psychopharmacology · doi:10.1007/bf02247440 · Cited by 39
Langlais, P. J., Mair, R. G., Anderson, C. D., & McEntee, W. J. (1987) · Brain Research · doi:10.1016/0006-8993(87)91284-4 · Cited by 39
Sahgal, A., Keith, A. B., Lloyd, S. R., Kerwin, J. M., Perry, E. K., & Edwardson, J. A. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90533-n · Cited by 39
Rapan, L., Froudist‐Walsh, S., Niu, M., Xu, T., Zhao, L., Funck, T., Wang, X., Amunts, K., & Palomero‐Gallagher, N. (2023) · eLife · doi:10.7554/elife.82850 · Cited by 39
Effect of huperzine A on working memory in reserpine- or yohimbine-treated monkeys
Ou, L. Y., Tang, X. C., & Cai, J. X. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01500-x · Cited by 38
Marighetto, A., Durkin, T., Toumane, A., Lebrun, C., & Jaffard, R. (1989) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(89)90557-1 · Cited by 39
Age-related differences in distractibility and response to methylphenidate in monkeys
Prendergast, M. (1998) · Cerebral Cortex · doi:10.1093/cercor/8.2.164 · Cited by 38
Clinton, S. M., Sucharski, I. L., & Finlay, J. M. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0221-2 · Cited by 37
Drosophila as a Novel Animal Model for Studying the Genetics of Age-related Memory Impairment
Saitoe, M., Horiuchi, J., Tamura, T., & Ito, N. (2005) · Reviews in the Neurosciences · doi:10.1515/revneuro.2005.16.2.137 · Cited by 35
Does “Benign Senescent Forgetfulness” Exist?
Bamford, K. A., & Caine, E. D. (1988) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(18)30724-9 · Cited by 37
Yi, F., Liu, S., Luo, F., Zhang, X., & Li, B. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12257 · Cited by 37
The Role of the Noradrenergic System in Autism Spectrum Disorders, Implications for Treatment
Beversdorf, D. Q. (2020) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2020.100834 · Cited by 35
Jentsch, J. D., & Anzivino, L. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1772-3 · Cited by 35
Flynn, B. L., & Ranno, A. E. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.17172 · Cited by 35
Friston, K. J., Grasby, P. M., Frith, C., Bench, C. J., Dolan, R. J., Cowen, P. J., Liddle, P. F., & Frackowiak, R. S. J. (2007) · Novartis Foundation symposium · doi:10.1002/9780470514184.ch5 · Cited by 34
Noradrenergic control of error perseveration in medial prefrontal cortex
Caetano, M. S., Jin, L. E., Harenberg, L., Stachenfeld, K., Arnsten, A. F. T., & Laubach, M. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2012.00125 · Cited by 35
Self-citationIs Methylphenidate Beneficial and Safe in Pharmacological Cognitive Enhancement?
Kapur, A. (2020) · CNS Drugs · doi:10.1007/s40263-020-00758-w · Cited by 36
Metadata
- Authors
- Arnsten, A. F. T., & Goldman-Rakic, P. S.
- Affiliations
- Yale University (US)
- Section of Neuroanatomy, Yale Medical School, New Haven, Connecticut 06510
- ORCID
- Arnsten, Amy F. T.
- Venue
- Science
- Published
- 1985-12-13
- Volume
- 230
- Issue
- 4731
- Pages
- 1273-1276
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2000247756
- Cited by
- 549
- References
- 29
- Citations by year
- 2026: 8 · 2025: 7 · 2024: 6 · 2023: 7 · 2022: 8 · 2021: 9 · 2020: 10 · 2019: 7 · 2018: 13 · 2017: 7 · 2016: 11 · 2015: 15 · 2014: 7 · 2013: 14 · 2012: 10
- FWCI
- 5.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (NIMH 00298, NIMH-08641, NIMH#38546)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- alpha2-adrenoceptors, clonidine, prefrontal cortex, cognitive decline, aging, non-human primates, memory disorders, adrenergic system, cognitive impairment
- MeSH terms
- Aging, Animals, Cerebral Cortex, Clonidine, Cognition, Female, Hydroxydopamines, Macaca mulatta, Memory, Prazosin, Receptors, Adrenergic, alpha, Yohimbine, Oxidopamine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
